Guselkumab 200 mg /20.0 ml(10mg/ml)

Guselkumab 200 mg in 2 mL solution (PFP).

Concentrate for solution for I.V infusion,

Guselkumab 200 mg /20.0 ml(10mg/ml).

- Solution for subcutaneous injection in pre-filled pen,

Each pre-filled pen contains: Guselkumab 200 mg in 2 mL solution

- Janssen-Cilag International NV, Turnhoutseweg 30, B-2340 Beerse - Belgium.

One dose (2 ml) contains rotavirus type*:

G1             ≥ 2.2 x 106 IU¹

 G2            ≥2.8 x 106 IU¹

G3               2.2 x 106 IU¹

G4              2.0 x 106 IU¹

P1A[8]        2.3 x 106 IU¹

* Human-bovine rotavirus reassortants (live), produced in Vero cell.

1 Infectious Units.

SOMATROPIN, RH-GH

Novo Nordisk A/S, Novo Alle 1, DK-2880 Bagsvaerd, Denmark - DENMARK

Each dose of 0.5ml contains:

Purified Hepatitis B Surface Antigen 10 µg.

Preservative Thiomersal 0.005 %.

Produced in hansenula polmorph (yeast) Adsorbed on aluminum hydroxide (AL +++) 0.25 mg to 0.40 mg.

Serum Institute of India Pvt. Ltd., 212/2, Hadapsar, Pune 411028 Maharashtra State - India.

Active immunization for the prevention of
varicella in individuals aged 1 year (12 months)
and above

Sinovac (Dalian) Vaccine Technology Co., Ltd.,No. 36, 2nd Life Road, DD Port, Economic and Technical Development Zone, Dalian, Liaoning Province, P.R - CHINA

Human Anti-D Immunoglobulin

Haemagglutinin of:

A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/9/2021, IVR-228) 15 mcg; A/Victoria/4897/2022 (H1N1) pdm09-like strain (A/Victoria/4897/2022, IVR-238) 15 mcg

B/Austria/1359417/2021-like strain (B/Michigan/01/2021, wild type) 15 mcg;

Pneumococcal Polysaccharide Serotype (1,3,4,5,6A,7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F) 2.2 ug ;

Pneumococcal Polysaccharide Serotype (6B) 4.4 ug